Comparative analysis of carboplatin and paclitaxel combination chemotherapy schedules in previously untreated patients with advanced non-small cell lung cancer

The combination of carboplatin and paclitaxel is one of the most commonly used regimens for the treatment of non-small cell lung cancer (NSCLC). We aimed to compare the standard tri-weekly and weekly schedules of this treatment, while considering treatment-related hematological toxicities. We retros...

Descripción completa

Detalles Bibliográficos
Autores principales: SHIMIZU, TOSHIKI, YOKOI, TAKASHI, TAMAKI, TAKESHI, KIBATA, KAYOKO, INAGAKI, NORIKO, NOMURA, SHOSAKU
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2013
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576211/
https://www.ncbi.nlm.nih.gov/pubmed/23426938
http://dx.doi.org/10.3892/ol.2013.1134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576211/
https://www.ncbi.nlm.nih.gov/pubmed/23426938
http://dx.doi.org/10.3892/ol.2013.1134

Ejemplares similares